BrightGene Bio (China) Price Prediction
| 688166 Stock | 29.55 0.68 2.36% |
Oversold Vs Overbought
45
Oversold | Overbought |
Quarterly Earnings Growth (0.1) | Wall Street Target Price 44.21 | Quarterly Revenue Growth (0.03) |
Using BrightGene Bio hype-based prediction, you can estimate the value of BrightGene Bio Medical from the perspective of BrightGene Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in BrightGene Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying BrightGene because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
BrightGene Bio after-hype prediction price | CNY 29.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BrightGene |
BrightGene Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of BrightGene Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BrightGene Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BrightGene Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BrightGene Bio Estimiated After-Hype Price Volatility
In the context of predicting BrightGene Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BrightGene Bio's historical news coverage. BrightGene Bio's after-hype downside and upside margins for the prediction period are 25.85 and 33.29, respectively. We have considered BrightGene Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BrightGene Bio is not too volatile at this time. Analysis and calculation of next after-hype price of BrightGene Bio Medical is based on 3 months time horizon.
BrightGene Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as BrightGene Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BrightGene Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BrightGene Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 3.72 | 0.02 | 0.00 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
29.55 | 29.57 | 0.07 |
|
BrightGene Bio Hype Timeline
BrightGene Bio Medical is presently traded for 29.55on Shanghai Stock Exchange of China. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.0. BrightGene is estimated to increase in value after the next headline, with the price projected to jump to 29.57 or above. The average volatility of media hype impact on the company the price is about 168.33%. The price jump on the next news is forecasted to be 0.07%, whereas the daily expected return is presently at 0.01%. The volatility of related hype on BrightGene Bio is about 4340.0%, with the expected price after the next announcement by competition of 29.55. The company reported the revenue of 1.18 B. Net Income was 200.58 M with profit before overhead, payroll, taxes, and interest of 670.14 M. Assuming the 90 days trading horizon the next estimated press release will be very soon. Check out BrightGene Bio Basic Forecasting Models to cross-verify your projections.BrightGene Bio Related Hype Analysis
Having access to credible news sources related to BrightGene Bio's direct competition is more important than ever and may enhance your ability to predict BrightGene Bio's future price movements. Getting to know how BrightGene Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BrightGene Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 603979 | JCHX Mining Management | (0.65) | 1 per month | 0.00 | (0.03) | 3.88 | (3.53) | 10.99 | |
| 600941 | China Mobile Limited | (1.60) | 2 per month | 1.17 | 0.01 | 2.20 | (2.15) | 6.82 | |
| 508058 | CICC Fund Management | 0.01 | 1 per month | 0.00 | 0.28 | 2.92 | (0.77) | 5.37 | |
| 688335 | Shanghai CEO Environmental | 0.05 | 2 per month | 0.00 | (0.05) | 3.24 | (4.09) | 10.19 | |
| 300590 | Queclink Wireless Solutions | 0.72 | 3 per month | 3.43 | 0.01 | 5.76 | (5.95) | 14.19 | |
| 600498 | Fiberhome Telecommunication Technologies | 0.15 | 2 per month | 2.54 | 0.07 | 4.93 | (4.21) | 13.82 | |
| 002148 | Beijing Bewinner Communications | 0.72 | 1 per month | 4.05 | 0.07 | 5.70 | (6.97) | 19.99 |
BrightGene Bio Additional Predictive Modules
Most predictive techniques to examine BrightGene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BrightGene using various technical indicators. When you analyze BrightGene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BrightGene Bio Predictive Indicators
The successful prediction of BrightGene Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as BrightGene Bio Medical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of BrightGene Bio based on analysis of BrightGene Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to BrightGene Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BrightGene Bio's related companies.
Story Coverage note for BrightGene Bio
The number of cover stories for BrightGene Bio depends on current market conditions and BrightGene Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BrightGene Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BrightGene Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
BrightGene Bio Short Properties
BrightGene Bio's future price predictability will typically decrease when BrightGene Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BrightGene Bio Medical often depends not only on the future outlook of the potential BrightGene Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BrightGene Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 422.5 M |
Complementary Tools for BrightGene Stock analysis
When running BrightGene Bio's price analysis, check to measure BrightGene Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightGene Bio is operating at the current time. Most of BrightGene Bio's value examination focuses on studying past and present price action to predict the probability of BrightGene Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightGene Bio's price. Additionally, you may evaluate how the addition of BrightGene Bio to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |